InvestorsHub Logo
Followers 60
Posts 7855
Boards Moderated 0
Alias Born 12/07/2007

Re: None

Thursday, 03/29/2018 5:20:05 PM

Thursday, March 29, 2018 5:20:05 PM

Post# of 5675
Favorable Benefit! Things moving along. “The data reviewed by both Committees to this point show that patients tolerate Trappsol® Cyclo™ well, and that Trappsol® Cyclo™ continues to have a favourable benefit:safety profile in this patient population," said Professor Boyd, on behalf of both Safety Review Committees.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTH News